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Synthesis and characterization of fluorogenic peptide 
substrate of HIV-1 protease based on fluorescence 
resonance energy transfer 
Synthesis of fluorogenic peptide substrate of HIV-1 protease Dns-SQNYPIVWL which corresponds to the 
pi?7p24 cleavage site forHIV-J protease havebeen performed. This fluorogenic substrate was based onthe 
fluorescence resonance energy transfer between donor — Trp residue, and acceptor — dansyl group in the 
intact peptide. Hydrolysis of substrate by recombinant HIV-1 protease resulted in the time-dependent 
increase ofTrp fluorescence and decrease of dansyl fluorescence measured at 350 and 500 nm, respectively, 
due to the break of resonance energy transfer between donor and acceptorfluorophors. Hydrolysis of fluoro­
genic peptide substrate was studied also by reversed phase HPLC and two peptide fragments after cleavage 
of substrate have been detected. Kinetic constants of hydrolysis for this fluorogenic peptide substrate by 
HIV-1 protease were calculated from Lineweaver— Burk plots: KM -29pM, kcat - 5.4 s'1 and kcailKM -
180 000 hf V і . -
Introduction* Human immunodeficiency virus protease (HIV-1 protease) per­
forms the proteolytic processing of viral gag and gag-pol polyproteins precursors 
during the replication cycle of retrovirus [1, 2]. It has been shown using site 
directed mutagenesis and also by use of specific inhibitors of HIV-1 protease 
that disruption of this function produces morphologically immature and 
noninfectious viral particles [3]. Thus, HIV-1 protease represents an important 
therapeutic target in the development of treatment for AIDS [4 ]. The number 
of specific inhibitors of HIV-1 protease have been synthesized and studied and 
results are summarized in reviews [5, 6 J. The antivirus synergy between HIV-1 
protease inhibitors and nucleoside analogue inhibitors of HIV reverse transcrip­
tase (AZT, ddC) has been also revealed [7 J. • 
Evaluation of efficiency of novel HIV-1 protease inhibitors requires the 
rapid and sensitive method of measurement of protease activity. Recently 
chromophoric peptide substrate for the spectrophotometric assay of HIV-1 
protease have been reported [8], which exhibits an absorbance increase upon 
its hydrolysis by protease. Fluorogenic peptide substrates of HIV-1 protease 
[9—11 ] are most efficient and sensitive in the monitoring of specific hydrolysis 
reaction. 
In this work we report the synthesis and characterization of fluorogenic 
peptide substrate of HIV-1 protease based on fluorescence resonance energy 
transfer (FRET). Resonance energy transfer between donor and acceptor 
chromophores is widely used as a tool for the measurement of intramolecular 
distances in biopolymers [12] and also to monitor the enzyme activity [9—11, 
13]. Our substrate was based on the FRET between two fluorescent probes, 
tryptophan and dansyl group, introduced into the oligopeptide substrate, which 
corresponds to the pi 7/p24 cleavage site for HIV-1 protease. 
Materials and Methods. Purification of HIV-1 protease. The expression 
system in Escherichia coli strain AR58 was as previously described by Meek et 
aL [14 ]. Cells (300 g) were thawed in 1500 ml of 50 mM Tris buffer containing 
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5 mM EDTA, 10 mM DTT and 1 mM PMSF, pH 8.0 and lysed with one pass 
through a Rainie cell disrupter at 6000 psi. Following centrifugation of the 
lysate at 30.000 * g for 60 min, the supernatant was drawn off and solid 
ammonium sulfate was added slowly to 35 % final concentration. After stirring 
for 60 min at 4 °С, the mixture was allowed to settle for 30 min prior to 
centrifugation at 30.000 * g for 60 min. The pellet was resuspended in a 
minimal volume of Superose 12 chromatography buffer (50 mM Tris buffer 
containing 5 mM EDTA, 10 mM DTT, 200 mM NaCl and 10 % glycerol, pH 
8.0) and dialyzed overnight at 4 °С against the same buffer. The dialysate was 
then clarified by centrifugation at 30.000 *g for 30 min and applied to a 
Superose 12 column (5 liters). Fractions were collected and assayed for HIV-1 
protease by reversed phase HPLC (RP-HPLC) and peak activity fractions were 
pooled, made 40 % v/v with glycerol and stored at -70 °С. The protein was 
judged to be greater than 95 % pure by SDS-PAGE and RP-HPLC analysis. 
Protease activity assay was conducted according to [14 J with substrate 
Ac-RASQNY • P W-NH2 . 
Synthesis of fluorogenic peptide substrate. Protected amino acids Boc-Leu, 
Boc-Ile, Boc-Val, Вое-Pro, Boc-Asn, Boc-Gln, N(a)-Boc-0-benzyl-L-Ser, 
N(a)-Boc-0-benzyl-L-Tyr and N(a)-Boc-(indolylformyl)-LrTrp were synthe­
sized as described [15]. 
Synthesis of fluorogenic peptide substrate of DnsSerGInAsnTyrProlleVal-
TrpLeu-OH was performed by peptide synthesizer using Merrifield resin 
(chloromethylated copolymer of styrol and divinylbenzole, particle size of 
200—400 mesh and active chlorine content of 0.7 mmole per 1 g of resin) 
obtained from Fluka (Switzerland). For synthesis convenience N (a)-Boc-Leu 
has been attached to the polymer as C-terminal amino acid by means of 
potassium salt in the presence of 18-crown-6-ether as catalyst [16]. 
H2N-SerGlnAsnTyrProIleVaITrpLeu-resin was dansylated by Dns-Cl. 
Dansylated peptide was isolated by pass of bromide hydrogen for 90 min 
through the resin suspension in trifluoroacetic acid (TFA), containing thio-
anizole. Formylaticm protection of Tip was removed by 0.1 M triethylamine in 
H20 for 10 min at 0 °С. The crude peptide (52 mg) was then purified to 
homogeneity by RP-HPLC. 
HPLC. Substrate purification, as well as the analysis of peptide fragments 
after cleavage of substrate by HIV-1 protease were performed on a Gold System 
(Beckinan), using either Ultrasphere C-18 column (10*250 mm) or Ultra-
sphere C-18 IP column (4.6 * 45 mm). Linear elution gradient of 0 to 80 % 
acetonitrile in 0.1% TFA was used in HPLC experiments. 
Fluorescence measurements. All measurements were performed on the 
Hitachi Model 850 fluorescence spectrophotometer (Japan), with a thermostated 
cell compartment at 20 eC. Fluorescence measurements were performed in 
0.5 * 0.5 cm2 quartz microcuvette. 
Fluorogenic peptide substrate Dns-SQNYPIVWL-OH was dissolved in 
50 % isopropanol. Then peptide solution was diluted by addition of reaction 
buffer, containing 0.05 M sodium acetate, pH 5J, 0.01 M dithiotreitol and 10 % 
glycerol. 
Kinetic analysis. Kinetic constants were determined from the fluorescence 
assay data of hydrolysis of fluorogenic substrate by HIV-1 protease. Initial rate 
of hydrolysis was calculated according to [171 as: v * FtlS]/(^'F0)ty where v 
— initial rate of hydrolysis (umole/min), [S] — concentration of substrate 
</*mole)r Ft — fluorescence intensity of substrate at the time t (t — time of 
hydrolysis, min), F — fluorescence intensity after complete hydrolysis and F0 
— initial fluorescence intensity. The kinetic parameters were obtained from the 
Lineweaver — Burk plots after linearization procedure performed using wEnz-
fitter" program. 
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Results. Design of structure of fluorogenic substrate. The amino acid 
sequence which corresponds to the pJ7/p24 cleavage site for HIV-1 protease 
was selected. This sequence was selected because it had been shown to be a 
better substrate for cleavage by HIV-1 protease than synthetic peptides based 
on other cleavage sites [18]. 
Trp residue was introduced into C-terminus of oligopeptide as a donor 
fluorophor Clmw at 355 nm) and dansyl group at N-terminus served as an 
acceptor fluorophor (Л
шах
 at 520 nm). Substrate design was based on the FRET 
between donor and acceptor groups in the intact peptide. Proteolytical cleavage 
of substrate by HIV-1 protease at the Tyr-Pro site should release two 
fluorophor-peptide fragments and break resonance energy transfer between Trp 
and Dns with concomitant changes of fluorescence intensities both of donor and 
acceptor fluorophors. 
Fluorescence properties of substrate. Fluorescence of fluorogenic substrate 
was excited at 290 nm and corrected emission spectra were recorded. Two 
emission bands at 355 and 520 nm (Trp and Dns emissions) were observed in 
the spectra. The ratio of fluorescence intensity of Dns to Trp fluorescence was 
about 1.8—2.0 in the intact substrate. 
Hydrolysis of substrate by HIV-J protease. Addition of HIV-1 protease 
(1.9 • 10~7 M) to substrate solution in the reaction buffer resulted in the changes 
of intensities of both fluorescence emission bands. Time-dependent increase of 
relative emission intensity of Trp fluorescence and decrease of dansyl fluore­
scence measured at 350 and 500 nm, respectively, are shown in Figure. These 
fluorescence changes were apparently due to the break of FRET between donor 
and acceptor fluorophors. 
Fluorescence intensities changes (excitation wavelength 
290 nm) of Dns-SQNYPIVWL-OH (concentration of 
2.5 -l<f5 M) in the course of its hydrolysis by HTV-1 
protease. Protease concentration was 1.9-10"' M. J — 
relative intensity change of tryptophan fluorescence 
measured at 350 nm; 2 — relative intensity change of 
dansyl fluorescence measured at 500 nm 
Hydrolysis ої fluorogenic peptide substrate was studied also by TtP-HPLC. 
Action of HIV-1 protease on Dns-SQNYPIVWL resulted in the appearance of 
two new peaks with retention times of 12.5 and 15.2 min. These species were 
characterized by fluorescence spectroscopy and identified as substrate fragments 
Dns-SQNY and PIVWL. These results suggest that fluorogenic substrate had 
been cleaved by HIV-1 protease at Tyr-Pro site. 
Kinetic parameters of hydrolysis. Kinetic studies of the hydrolysis reaction 
were performed at nine different concentrations of fluorogenic substrate. The 
kinetic constants of HIV-1 protease-catalyzed cleavage were calculated from 
Lineweaver — Burk plots. For this fluorogenic peptide substrate the values 
KM • 29 ^M and £ttt - 5.4 s"1 were obtained. These kinetic constants are close 
to the values obtained by Matayoshi et al. [9 ] for the hydrolysis of fluorogenic 
substrate based on the same p!7/p24 cleavage site (К
ы
 - 103 ^M and 
*«i • 4.9 s~\ respectively). 
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Discussion. Different methods have been used for the measurement of 
proteolytic activity of HIV-proteases, including HPLC analysis of cleavage 
fragments [141, protein immunoblot analysis, spectrophotometric assay using 
chromophoric peptide substrate [8 ]. Most of these methods are time-consuming 
and unacceptable for screening of large number of HIV-protease inhibitors, 
Fluorogenic peptide substrates of HIV-1 protease are based on fluorescence 
assay of its proteolytic activity. This method is very sensitive and provides an 
accurate determination of kinetic parameters of hydrolysis reaction. 
Fluorogenic peptide substrate of HIV-1 protease Dns-SQNYPIVWL 
described in this work was based on the FRET between Trp as a donor and 
Dns as an acceptor molecules. This donor-acceptor pair is very suitable for 
energy transfer measurements. It is known that FRET measurements are most 
sensitive to distance variation when donor-acceptor separation is close to their 
Fbrster distance [12]. The value of Forster distance using Trp as a donor and 
Dns as an acceptor of resonance energy transfer R0 --21 A [12], which 
corresponds well to the length of peptide separating two fluorescent probes in 
fluorogenic substrate. Our fluorogenic substrate is similar to substrate described 
by Geoghegan et al. [11 ] but it has much better ratio к
ш
/К
ч
 « 180 000 M'V1. 
The solubility of this fluorogenic substrate may be increased by addition of 
other hydrophilic groups into its structure, e.g. by incorporation of Arg residues 
at the C- and N-ends of substrate. 
Fluorogenic peptide substrate of HIV-1 protease based on FRET may be 
used not only in steady-state fluorescence measurements but also in liquid 
chromatography assays, microscopy and other biological and clinical 
applications. 
A. I. Корнелюк, А Г. Терентьсв, С. Фішер, Т. Портер 
СИНТЕЗ ТА ХАРАКТЕРИСТИКА ФЛЮОРОГЕННОГО 
ПЕПТИДНОГО СУБСТРАТУ ВІЛ-1 ПРОТЕАЗИ НА ОСНОВІ 
ФЛЮОРЕСЦЕНТНОГО РЕЗОНАНСНОГО ПЕРЕНОСУ ЕНЕРГВ 
Резюме 
Проведено хімічний синтез флюорогенного пептидного субстрату ВІЛ-1 протеази, що має 
структуру Dns-SQNYPIVWL і відповідає сайту розщеплення рІ7Ір24 у gag-поліпротеіні вірусу 
імунодефіциту людини.Принцип використання даного субстрату базується на резонансному 
переносі енергії збудження між донором — залишком Т ф і акцептором — дансильною групою. 
Встановлено, що гідроліз флюорогенного пептидного субстрату рекомбінантною ВІЛ-1 протеа­
зою призводить до падіння інтенсивності флюоресценції дансильної групи і одночасного 
зростання триптофанової флюоресценції внаслідок порушення резонансного переносу енергії 
між донором і акцептором. За допомогою високоефективної рідинної хроматографії в оберненій 
фазі зафіксовано появу пептидів, які є продуктами гідролізу субстрату. Визначено кінетичні 
параметри гідролізу флюорогенного пептидного субстрату ВІЛ-1 протеазою: Кц - 29 мкМ, Jfe^ t — 
- 5,4 с та *ои'Км - 180 000 M'V1 . 
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